Cholestin Red Yeast Rice Shipments Halted Pending FDA Talks
This article was originally published in The Tan Sheet
Executive Summary
Pharmanex suspended U.S. shipments of Cholestin April 2 following a federal court decision affirming FDA's determination that the red yeast rice product is a drug, not a dietary supplement.
You may also be interested in...
Questions Circle INDs; Industry Needs Guidance For Probiotics, Say Experts
FDA should consider issuing a guidance for probiotics similar to the 2004 industry guidance for botanical drugs, panelists said at a recent Drug Information Association conference
Questions Circle INDs; Industry Needs Guidance For Probiotics, Say Experts
FDA should consider issuing a guidance for probiotics similar to the 2004 industry guidance for botanical drugs, panelists said at a recent Drug Information Association conference
Questions Circle INDs; Industry Needs Guidance For Probiotics, Say Experts
FDA should consider issuing a guidance for probiotics similar to the 2004 industry guidance for botanical drugs, panelists said at a recent Drug Information Association conference